ANI Pharmaceuticals, Inc. Reports Record Net Revenues Of $10.9 Million, EPS Of $0.33, And Adjusted Non-GAAP EBITDA Of $4.2 Million For The First Quarter Ended March 31, 2014
ANI Pharmaceuticals Reports Record Net Revenues Of $10.9 Million, EPS Of $0.33, And Adjusted Non-GAAP EBITDA Of $4.2 Million For The First Quarter Ended March 31, 2014